Guardian Pharmacy Services (GRDN) reported Q4 earnings Wednesday of $0.19 per diluted share.
Three analysts polled by FactSet expected earnings of $0.22 per diluted share.
The company completed its initial public offering in September 2024.
Revenue for the quarter ended Dec. 31 was $338.6 million, up from $281.1 million a year ago.
Three analysts surveyed by FactSet expected $332.8 million.
The company said it expects full-year 2025 revenue between $1.33 billion and $1.35 billion.
Three analysts polled by FactSet expect $1.34 billion.
Shares of Guardian Pharmacy were down 0.3% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.